Patient Guide: A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 46 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05342636
Status: ACTIVE_NOT_RECRUITING
Condition: Esophageal Squamous Cell Carcinoma (ESCC)
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 46 locations across the country.

Top locations include:
  • • Natal, Rio Grande Do Norte
  • • Porto Alegre, Rio Grande Do Sul
  • • São Paulo, Sao Paulo
  • • And 43 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) - Join Clinical Trial NCTNCT05342636

How to Join This Clinical Trial - NCTNCT05342636

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Esophageal Squamous Cell Carcinoma (ESCC). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Esophageal Squamous Cell Carcinoma (ESCC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Esophageal Squamous Cell Carcinoma (ESCC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05342636 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 46 locations. Find a study site near you:

Clinical Research Site

Natal, Rio Grande Do Norte 59062-000 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande Do Sul 91350-200 - Brazil

Status: Contact for availability

Clinical Research Site

São Paulo, Sao Paulo 01246-000 - Brazil

Status: Contact for availability

Clinical Research Site

Santiago, Region M. De Santiago 7500921 - Chile

Status: Contact for availability

Clinical Research Site

Santiago, Region M. De Santiago 7591047 - Chile

Status: Contact for availability

Clinical Research Site

Brest, Finistere 29200 - France

Status: Contact for availability

Clinical Research Site

Lille, Nord 59037 - France

Status: Contact for availability

Clinical Research Site

Paris, Orne 75013 - France

Status: Contact for availability

Clinical Research Site

Frankfurt, Hessen 60488 - Germany

Status: Contact for availability

Clinical Research Site

Düsseldorf, Nordrhein-Westfalen 40225 - Germany

Status: Contact for availability

And 36 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Esophageal Squamous Cell Carcinoma (ESCC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships